Replies to post #420132 on Amarin Corp Plc (AMRN)

[Tatsumaki]

Yes, the licensed product from Mochida.

[CaptBeer]

No MND-2119 is the the Lymphatic System delivery method. It’s a self-emulsifying molecule that delivers twice as much EPA per dose than the original capsule. Thus reducing the current dose of 2g twice daily to 2g once daily. This product is currently Rxing in Japan.